B.A.M. Heemskerk-Gerritsen

Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs et al. · International Journal of Cancer · 2014 · 213 citations · Full text

Medicine, Oncology, Breast Oncology +14

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

B.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, C. J. van Asperen et al. · JNCI Journal of the National Cancer Institute · 2015 · 206 citations · Full text

Medicine, Gynecology, Oncology +17

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis

B.A.M. Heemskerk-Gerritsen, Marian B. E. Menke‐Pluijmers, Agnes Jager et al. · Annals of Oncology · 2013 · 117 citations · Full text

Medicine, Molecular Genetics, Oncology +17

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases

Nadine S. van den Ende, Marcel Smid, A. Mieke Timmermans et al. · Scientific Reports · 2022 · 54 citations · Full text

Medicine, Oncology, Pathology +17

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study

Delal Akdeniz, Mark van Barele, B.A.M. Heemskerk-Gerritsen et al. · The Breast · 2021 · 34 citations · Full text

Medicine, Oncology, Breast Oncology +10